Farooq Wandroo

9PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Foetal development and medicineCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 14, 2023
Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial.

Stella Bowcock, Catherine Atkin, Gulnaz Iqbal

|Jun 12, 2023
Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes.

Justin Loke, Vinit Upasani, Charlotte Gaskell

|May 23, 2023
A Report of a Symptomatic Progressive Myeloma during Pregnancy and Postpartum Period from Asymptomatic State.

Gehad Elgabry, Lydia Spencer, Hisam Siddiqi

|Feb 23, 2023
Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis.

Annabel McMillan, Supratik Basu, Kamaraj Karunanithi

|Jan 08, 2023
Lactate Dehydrogenase/Albumin To-Urea Ratio: A Novel Prognostic Maker for Fatal Clinical Complications in Patients with COVID-19 Infection.

Hala Shokr, Mandeep Kaur Marwah, Hisam Siddiqi

|Mar 05, 2022
SARS-2 COVID-19-induced immunity response, a new prognostic marker for the pregnant population correlates inversely with neonatal Apgar score.

M Marwah, H Shokr, A Demitry

Pageof 2

Frequent Collaborators

3 joint publications

Guy Pratt

1 joint publications

Nicholas C P Cross

1 joint publications

Mary Frances McMullin

1 joint publications

Adam J Mead